Clinical Trial Update: A Study to Determine the Safety and Efficacy of TG-C in Subjects With Kellgren and Lawrence Grade 2 or 3 OA of the Knee [Phase 3]

View source ↗

Summary

Phase 3 trial assessing safety and efficacy of TG-C in Kellgren and Lawrence grade 2-3 knee osteoarthritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Degenerative Osteoarthritis of the Knee

Drugs mentioned

• TG-C (tissueGene-C)

Snippet

Sponsor: Kolon TissueGene, Inc. | Conditions: Degenerative Osteoarthritis | Phase 3 | Status: ACTIVE_NOT_RECRUITING